<PAPER>
  <mode2 name="ehp_5_arathi" hasDoc="yes" version="1258"/>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
    <front>
      <journal-meta>
        <journal-id journal-id-type="publisher-id">EHP</journal-id>
        <journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
        <journal-title>Environmental Health Perspectives</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Environ. Health Perspect.</abbrev-journal-title>
        <issn pub-type="epub">0091-6765</issn>
        <publisher>
          <publisher-name>National Institute of Environmental Health Sciences</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="publisher-id">ehp-116-1661</article-id>
        <article-id pub-id-type="doi">10.1289/ehp.11515</article-id>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject/>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
            <s sid="1">Respiratory Cancer and Inhaled Inorganic Arsenic in Copper Smelters Workers: A Linear Relationship with Cumulative Exposure that Increases with Concentration<CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/></s>
          </article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author" corresp="yes" xlink:type="simple">
            <name name-style="western">
              <surname>Lubin</surname>
              <given-names>Jay H.</given-names>
            </name>
            <xref ref-type="aff" rid="af1-ehp-116-1661">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Moore</surname>
              <given-names>Lee E.</given-names>
            </name>
            <xref ref-type="aff" rid="af2-ehp-116-1661">
              <sup>2</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Fraumeni</surname>
              <given-names>Joseph F.</given-names>
            </name>
            <xref ref-type="aff" rid="af3-ehp-116-1661">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" xlink:type="simple">
            <name name-style="western">
              <surname>Cantor</surname>
              <given-names>Kenneth P.</given-names>
            </name>
            <xref ref-type="aff" rid="af2-ehp-116-1661">
              <sup>2</sup>
            </xref>
          </contrib>
          <aff id="af1-ehp-116-1661">
            <label>1</label>
            <addr-line> Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA</addr-line>
          </aff>
          <aff id="af2-ehp-116-1661">
            <label>2</label>
            <addr-line> Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Rockville, Maryland, USA</addr-line>
          </aff>
          <aff id="af3-ehp-116-1661">
            <label>3</label>
            <addr-line> Office of the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA</addr-line>
          </aff>
        </contrib-group>
        <author-notes>
          <corresp>Address correspondence to J.H. Lubin, Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., Room 8042, Rockville, MD 20852 USA. Telephone: (301) 496-3357. Fax: (301) 402-0081. E-mail: lubinj@mail.nih.gov</corresp>
          <fn id="fn1">
            <p>The authors declare they have no competing financial interests.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>23</day>
          <month>7</month>
          <year>2008</year>
        </pub-date>
        <volume>116</volume>
        <issue>12</issue>
        <fpage>1661</fpage>
        <lpage>1665</lpage>
        <history>
          <date date-type="received">
            <day>27</day>
            <month>3</month>
            <year>2008</year>
          </date>
          <date date-type="accepted">
            <day>23</day>
            <month>7</month>
            <year>2008</year>
          </date>
        </history>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/" xlink:type="simple">
          <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
        </license>
        <permissions>
          <copyright-year>2008</copyright-year>
          <copyright-holder/>
        </permissions>
        <abstract>
          <sec>
            <title>Background</title>
            <p>
              <s sid="2">Inhalation of high levels of airborne inorganic arsenic is a recognized cause of respiratory cancer.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/></s>
              <s sid="3">Although multiple epidemiologic studies have demonstrated this association, there have been few analyses of the mathematical relationship between cumulative arsenic exposure and risk of respiratory cancer, and no assessment as to whether and how arsenic concentration may modify this association.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Objectives</title>
            <p>
              <s sid="4">The objective is an evaluation of the shape of the relationship between respiratory cancer mortality and cumulative inhaled arsenic exposure among copper smelter workers, and the modification of that relationship by arsenic concentration.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Methods</title>
            <p>
              <s sid="5">We used Poisson regression methods to analyze data from a cohort of arsenic-exposed copper smelter workers under a linear-exponential model for the excess relative risk.<CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Results</title>
            <p>
              <s sid="6">Within categories of arsenic concentration, the association between respiratory cancer and cumulative arsenic exposure was consistent with linearity.<CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/></s>
              <s sid="7">The slope of the linear relationship with cumulative exposure increased with increasing arsenic concentration category.<CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/></s>
            </p>
          </sec>
          <sec>
            <title>Conclusions</title>
            <p>
              <s sid="8">Our results suggested a direct concentration effect from inhaled inorganic arsenic, whereby the excess relative risk for a fixed cumulative exposure was greater when delivered at a higher concentration and shorter duration than when delivered at a lower concentration and longer duration.<CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/></s>
            </p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>arsenic</kwd>
          <kwd>dose</kwd>
          <kwd>response relationship</kwd>
          <kwd>lung neoplasms</kwd>
          <kwd>occupational diseases</kwd>
        </kwd-group>
      </article-meta>
    </front>
    <body>
      <p>
        <s sid="9">The <xref ref-type="bibr" rid="b16-ehp-116-1661">International Agency for Research on Cancer (1980</xref>, <xref ref-type="bibr" rid="b17-ehp-116-1661">1987</xref>) identifies inhalation of inorganic arsenic as a cause of lung cancer in humans.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/></s>
        <s sid="10">The evidence has come primarily from epidemiologic studies of miners and smelter workers who inhaled high levels of inorganic arsenic in airborne dust.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/></s>
        <s sid="11">Although increased risk of lung cancer from inhaled arsenic appears related to direct effects on the respiratory tract, there may be a systemic effect as well, because ingestion of high amounts of inorganic arsenic in drinking water has been associated with lung cancer mortality at levels comparable with occupational risks from inhaled arsenic (<xref ref-type="bibr" rid="b4-ehp-116-1661">Bates et al. 1992</xref>; <xref ref-type="bibr" rid="b30-ehp-116-1661">Lubin et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/></s>
        <s sid="12">Information on the mathematical relationship between cumulative inhaled arsenic exposure and respiratory cancer mortality is limited.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/></s>
        <s sid="13">Although a comparative evaluation of several occupational cohorts, mostly smelter workers, suggested a concave relationship between respiratory cancer mortality and cumulative arsenic exposure (<xref ref-type="bibr" rid="b12-ehp-116-1661">Hertz-Picciotto and Smith 1993</xref>), a subsequent update of one large study revealed that its apparent nonlinearity was an artifact of exposure assessment and that relative risk (RR) trends with cumulative arsenic exposure were consistent with a linear relationship (<xref ref-type="bibr" rid="b30-ehp-116-1661">Lubin et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/></s>
        <s sid="14">Previous analyses have focused on cumulative arsenic exposure and the shape of the exposure&#8211;response relationship, without considering the possible influence of arsenic concentration.<CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="15">In the present analysis, we applied a novel methodology used previously in a study of smoking-related lung cancer (<xref ref-type="bibr" rid="b28-ehp-116-1661">Lubin and Caporaso 2006</xref>) to model cumulative arsenic exposure and arsenic concentration.<CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="None" advantage="None"/></s>
        <s sid="16">In particular, we examined the consequences of exposure &#8220;delivery,&#8221; that is, whether the RR of respiratory cancer at a fixed cumulative exposure delivered at higher arsenic concentration for shorter duration was greater than, equal to, or less than the RR from an equal cumulative exposure delivered at lower concentration for longer duration.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/></s>
        <s sid="17">We refer to these patterns as direct (increasing), constant (no variation), or inverse (decreasing) &#8220;exposure rate&#8221; effects.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj2" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="18">Standard analyses of joint RRs by duration of arsenic exposure and arsenic concentration with nonexposed individuals as the referent group are problematic for characterizing the effects of arsenic concentration, because cumulative exposure varies.<CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="None" advantage="None"/></s>
        <s sid="19">For illustration, consider duration of cigarette smoking, smoking intensity (cigarettes smoked per day), and total pack-years (years of smoking times cigarettes per day divided by 20).<CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/></s>
        <s sid="20">In a standard log-linear RR regression model that includes duration of smoking and cigarettes per day, the intensity parameter represents the ln(RR) per cigarette per day at a fixed duration.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/></s>
        <s sid="21">Interpretation of the duration parameter is similar but at a fixed intensity.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/></s>
        <s sid="22">A comparison of RRs at two different intensities reflects not only different intensities, but also different total pack-years.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/></s>
        <s sid="23">For example, at 30 years&#8217; duration, RRs at 20 and 30 cigarettes per day reflect different intensities and different total pack-years&#8212;namely, 30 and 45 pack-years, respectively.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/></s>
        <s sid="24">Thus, RR patterns with duration and intensity cannot be viewed as &#8220;independent&#8221; because of the intrinsic confounding of pack-years.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/></s>
        <s sid="25">In contrast, in a model that includes pack-years and cigarettes per day, the parameter for cigarettes per day represents the comparison of risk for exposure delivered at lower intensity for longer duration with risk for an equal total exposure delivered at higher intensity for shorter duration (<xref ref-type="bibr" rid="b28-ehp-116-1661">Lubin and Caporaso 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/></s>
        <s sid="26">We use this framework to analyze inhalation of airborne inorganic arsenic in a cohort mortality study of smelter workers conducted in Montana (<xref ref-type="bibr" rid="b23-ehp-116-1661">Lee and Fraumeni 1969</xref>; <xref ref-type="bibr" rid="b24-ehp-116-1661">Lee-Feldstein 1983</xref>; <xref ref-type="bibr" rid="b29-ehp-116-1661">Lubin et al. 1981</xref>, <xref ref-type="bibr" rid="b30-ehp-116-1661">2000</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met5" novelty="None" advantage="None"/></s>
      </p>
      <p>
        <s sid="27">Our goal of modeling the cumulative airborne arsenic exposure and arsenic concentration is to estimate a descriptive function that defines the modifying effect of concentration on the association between cumulative exposure and respiratory cancer.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/></s>
        <s sid="28">This effect modification is conceptually similar to the &#8220;dose rate effective factor&#8221; used in radiation epidemiology that describes for a specific type of radiation the effects on disease risk of total radiation dose delivered at lower (protracted or highly fractionated) dose rates compared with the effects at higher (or acute) dose rates (<xref ref-type="bibr" rid="b34-ehp-116-1661">National Research Council 2006</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met6" novelty="None" advantage="None"/></s>
      </p>
      <sec sec-type="materials|methods">
        <title>Materials and Methods</title>
        <sec sec-type="methods">
          <title>Data</title>
          <p>
            <s sid="29">The cohort study enrolled workers employed at a Montana copper smelter for &#8805;1 year before 1957, with follow-up starting 1 year after initial employment or 1 January 1938, whichever was later (<xref ref-type="bibr" rid="b23-ehp-116-1661">Lee and Fraumeni 1969</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/></s>
            <s sid="30">The present analysis included 8,014 workers followed through 1989 (<xref ref-type="bibr" rid="b30-ehp-116-1661">Lubin et al. 2000</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/></s>
            <s sid="31">We determined vital status from the National Death Index (<ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/ndi.htm" xlink:type="simple">http://www.cdc.gov/nchs/ndi.htm</ext-link>) and other sources, with causes of death recorded from death certificates.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/></s>
            <s sid="32">A total of 4,930 (62%) workers were deceased.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/></s>
            <s sid="33">Following previous analyses of this cohort, we consider respiratory cancer mortality as the primary outcome.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="34">In the 1960s, investigators ranked each work site from 1 to 10 for its potential arsenic exposure and classified each site as &#8220;heavy&#8221; (ranks 8&#8211;10), &#8220;medium&#8221; (ranks 4&#8211;7), or &#8220;light&#8221; (ranks 1&#8211;3) arsenic exposure areas (<xref ref-type="bibr" rid="b23-ehp-116-1661">Lee and Fraumeni 1969</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met7" novelty="None" advantage="None"/></s>
            <s sid="35">We classified unspecified or unknown work areas as light exposure areas.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/></s>
            <s sid="36">We subsequently updated employment information through September 1977 (<xref ref-type="bibr" rid="b25-ehp-116-1661">Lee-Feldstein 1986</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/></s>
            <s sid="37">Using 702 measurements of airborne arsenic from 1943 through 1958 and estimates of workers&#8217; exposure times, investigators computed time-weighted average arsenic concentrations for light, medium, and heavy arsenic-exposed areas as 0.29, 0.58, and 11.3 mg/m<sup>3</sup>, respectively (<xref ref-type="bibr" rid="b33-ehp-116-1661">Morris 1978</xref>).<CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/></s>
            <s sid="38">For each year of follow-up, we computed a cumulative exposure index in mg/m<sup>3</sup>-year, denoted <italic>d</italic>, as the product of years worked in light (L), medium (M), and heavy (H) exposure areas and the corresponding concentration&#8212;that is, <italic>d</italic> = 0.29 &#215; L + 0.58 &#215; M + 1.13 &#215; H&#8212;where we down-weighted heavy exposure areas by a factor of 0.1 to reflect use of air filtration masks.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/></s>
            <s sid="39">This <italic>a priori</italic> choice of weight was similar to an empirically derived, risk-based estimate of weight (<xref ref-type="bibr" rid="b29-ehp-116-1661">Lubin et al. 1981</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met8" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="40">Many workers had recorded ages at last employment of &lt; 40 and 50 years.<CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/></s>
            <s sid="41">Because there was no information on exposures after the workers left the smelter, we repeated analyses using person-years and respiratory cancer deaths in current workers, recent former (&lt; 5 years) workers, and workers with last employment at &#8805; 50 years of age to minimize effects of unmeasured exposures.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/></s>
            <s sid="42">The restricted subset included 261 respiratory cancer cases and 144,851 person-years.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/></s>
            <s sid="43">The number of respiratory cancer cases differed from a previous report (<italic>n</italic> = 252) (<xref ref-type="bibr" rid="b30-ehp-116-1661">Lubin et al. 2000</xref>) because of a modified definition of the restrictions.<CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/></s>
          </p>
        </sec>
        <sec sec-type="methods">
          <title>Statistical analysis</title>
          <p>
            <s sid="44">We assumed survival time follows a piecewise exponential distribution and applied Poisson regression methods.<CoreSc1 atype="GSC" type="Met" conceptID="Met9" novelty="None" advantage="None"/></s>
            <s sid="45">We summarized deaths from respiratory cancer and person-years of follow-up in a multiway contingency table defined by attained age (nine levels: &lt; 45, 45&#8211;49, ... ,75&#8211;79, &#8805; 80), calendar year (10 levels: 1935&#8211;39, ... ,1985&#8211;90), cumulative arsenic exposure (mg/m<sup>3</sup>-year; 18 levels: &lt; 0.25, 0.25&#8211;0.49, 0.50&#8211;0.74, 0.75&#8211;0.99, 1.0&#8211;1.4, 1.5&#8211;1.9, 2.0&#8211;3.9, ... , 22&#8211;24.9, &#8805;25), mean arsenic concentration (mg/m<sup>3</sup>; eight levels: 0, 0.01&#8211;0.29, 0.3&#8211;0.39, 0.4&#8211;0.49, 0.5&#8211;0.59, 0.6&#8211;0.79, 0.8&#8211;0.99, &#8805;1.0), years since last arsenic exposure (three levels: &lt; 5, 5&#8211;14, &#8805; 15), and place of birth (two levels: U.S. or foreign born).<CoreSc1 atype="GSC" type="Met" conceptID="Met10" novelty="None" advantage="None"/></s>
            <s sid="46">For each cell of the cross-classification, we computed person-year&#8211;weighted means for the cross-classification variables.<CoreSc1 atype="GSC" type="Met" conceptID="Met11" novelty="None" advantage="None"/></s>
            <s sid="47">Because all workers were exposed to arsenic, we used age-specific and calendar-year-specific U.S. mortality rates for respiratory cancer in white males as a nonexposed referent population (<xref ref-type="bibr" rid="b5-ehp-116-1661">Breslow and Day 1987</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met12" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="48">We defined indicator variables <italic>c</italic><italic><sub>i</sub></italic>, <italic>i</italic> = 1, ... , <italic>I</italic>, for <italic>I</italic> concentration categories where <italic>c</italic><italic><sub>i</sub></italic> = 1 for intensities within category <italic>i</italic> and zero otherwise, and modeled disease rate <italic>r</italic>(<italic>x</italic>,<italic>d</italic>,<italic>c</italic>) as<CoreSc1 atype="GSC" type="Met" conceptID="Met13" novelty="None" advantage="None"/></s>
          </p>
          <disp-formula>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.e001" xlink:type="simple"/>
          </disp-formula>
          <p>
            <s sid="49">where <italic>d</italic> is cumulative arsenic exposure and <italic>c</italic> is arsenic concentration.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj3" novelty="None" advantage="None"/></s>
            <s sid="50">The vectors of variables <italic>x</italic> and parameters &#945;, where <italic>T</italic> denotes vector transpose, describe disease rates in non-exposed workers.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj4" novelty="None" advantage="None"/></s>
            <s sid="51">Within concentration category <italic>i</italic>, RRs are linear in <italic>d</italic>; that is, RR(<italic>d</italic>,<italic>c</italic>) = 1 + &#947;<italic><sub>i</sub></italic><italic>d</italic>, where &#947;<italic><sub>i</sub></italic> is the slope of the linear exposure&#8211;response, or ERR/mg/m<sup>3</sup>-year (ERR, excess relative risk).<CoreSc1 atype="GSC" type="Obj" conceptID="Obj5" novelty="None" advantage="None"/></s>
            <s sid="52">We used Wald-type confidence intervals (CIs) for &#947;<italic><sub>i</sub></italic> after reparameterizing &#947;<italic><sub>i</sub></italic> as exp(&#947;<italic><sub>i</sub></italic>*) to avoid range restrictions.<CoreSc1 atype="GSC" type="Met" conceptID="Met14" novelty="None" advantage="None"/></s>
            <s sid="53">Factoring out &#947;<sub>1</sub>, we rewrote RR(<italic>d</italic>,<italic>c</italic>) as<CoreSc1 atype="GSC" type="Met" conceptID="Met15" novelty="None" advantage="None"/></s>
          </p>
          <disp-formula>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.e002" xlink:type="simple"/>
          </disp-formula>
          <p>
            <s sid="54">which suggested the following model for continuous concentration:<CoreSc1 atype="GSC" type="Met" conceptID="Met16" novelty="None" advantage="None"/></s>
          </p>
          <disp-formula>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.e003" xlink:type="simple"/>
          </disp-formula>
          <p>
            <s sid="55">where &#946; defined ERR/mg/m<sup>3</sup>-year at <italic>g</italic>(<italic>c</italic>) = 1.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj6" novelty="None" advantage="None"/></s>
            <s sid="56">The <italic>g</italic>(.) function represents the modifying effects of arsenic concentration on the exposure&#8211;response relationship.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj7" novelty="None" advantage="None"/></s>
            <s sid="57">Preliminary analysis suggested using the power form <italic>g</italic>(<italic>c</italic>) = exp{&#966; ln(<italic>c</italic>)}, where &#966; &gt; 0, &#966; = 0, or &#966; &lt; 0 denotes a direct (increasing), constant (no variation), or inverse (decreasing) concentration effect, respectively.<CoreSc1 atype="GSC" type="Mod" conceptID="Mod2" novelty="None" advantage="None"/></s>
            <s sid="58">Model fit did not improve with the addition of <italic>c</italic> or ln(<italic>c</italic>)<sup>2</sup>.<CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="59">We extended model 1 to<CoreSc1 atype="GSC" type="Met" conceptID="Met17" novelty="None" advantage="None"/></s>
          </p>
          <disp-formula>
            <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.e004" xlink:type="simple"/>
          </disp-formula>
          <p>
            <s sid="60">to evaluate departure from linearity, where &#948;<italic><sub>i</sub></italic> reflects concavity (&#948;<italic><sub>i</sub></italic> &lt; 0) or convexity (&#948;<italic><sub>i</sub></italic> &gt; 0) of the ERRs with cumulative exposure for the <italic>i</italic>th concentration category.<CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/></s>
            <s sid="61">The null hypothesis &#948;<italic><sub>i</sub></italic> = 0 specified no departure from linearity.<CoreSc1 atype="GSC" type="Met" conceptID="Met18" novelty="None" advantage="None"/></s>
            <s sid="62">We applied a similar extension to model 2.<CoreSc1 atype="GSC" type="Met" conceptID="Met19" novelty="None" advantage="None"/></s>
          </p>
          <p>
            <s sid="63">Because all workers were exposed, we included the natural logarithm of the age- and year-specific respiratory cancer rates of U.S. males as a fixed offset variable (<italic>x</italic>) to represent rates in nonexposed workers.<CoreSc1 atype="GSC" type="Met" conceptID="Met20" novelty="None" advantage="None"/></s>
            <s sid="64">The model thus represented a regression equation for standardized mortality ratios (SMR) (<xref ref-type="bibr" rid="b5-ehp-116-1661">Breslow and Day 1987</xref>).<CoreSc1 atype="GSC" type="Mod" conceptID="Mod3" novelty="None" advantage="None"/></s>
            <s sid="65">Although model 2 reflected relative SMRs, we refer to quantities as RRs.<CoreSc1 atype="GSC" type="Met" conceptID="Met21" novelty="None" advantage="None"/></s>
            <s sid="66">For analyses, we used the Epicure suite of programs (<xref ref-type="bibr" rid="b36-ehp-116-1661">Preston et al. 2004</xref>).<CoreSc1 atype="GSC" type="Met" conceptID="Met22" novelty="None" advantage="None"/></s>
          </p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p>
          <s sid="67">The person-year&#8211;weighted mean cumulative arsenic exposure was 3.7 mg/m<sup>3</sup>-years, with a crude respiratory cancer mortality rate of 1.73 per 1,000 person-years, based on 446 total respiratory cancer deaths (<xref ref-type="table" rid="t1-ehp-116-1661">Table 1</xref>).<CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/></s>
          <s sid="68">The SMR for respiratory cancer was 1.56 (95% CI, 1.4&#8211;1.7).<CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/></s>
          <s sid="69">In the restricted data, the mean cumulative arsenic exposure was 5.4 mg/m<sup>3</sup>-years, the crude respiratory mortality rate per 1,000 person-years was 1.80, and the SMR was 1.87 (95% CI, 1.7&#8211;2.1).<CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="70">SMRs increased with cumulative arsenic exposure and with arsenic concentration (<xref ref-type="table" rid="t2-ehp-116-1661">Table 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/></s>
          <s sid="71">The SMR in the lowest concentration category was significantly elevated, suggesting a difference between respiratory cancer mortality rates for U.S. males and a hypothetical group of nonexposed workers.<CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/></s>
          <s sid="72">We fitted model 1 with continuous cumulative arsenic exposure and six categories of arsenic concentration and estimated respiratory cancer rates in a hypothetical group of nonexposed workers relative to the standard population.<CoreSc1 atype="GSC" type="Met" conceptID="Met23" novelty="None" advantage="None"/></s>
          <s sid="73">After adjustment for arsenic exposure, SMRs for nonexposed workers were 3.10 (95% CI, 2.3&#8211;4.2), 2.22 (95% CI, 1.6&#8211;3.1), and 1.44 (95% CI, 1.1&#8211;2.0) for calendar periods &lt; 1960, 1960&#8211;69, and &#8805;1970, respectively, and the effect of U.S. birth relative to foreign birth was 0.67 (95% CI, 0.5&#8211;0.9).<CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/></s>
          <s sid="74">SMRs did not vary significantly with attained age.<CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/></s>
          <s sid="75">We included offset parameters fixed at the logarithms of these &#8220;nonexposed&#8221; SMRs to adjust for differences between &#8220;nonexposed&#8221; workers and the standard population.<CoreSc1 atype="GSC" type="Met" conceptID="Met24" novelty="None" advantage="None"/></s>
          <s sid="76">After adjustment, SMRs increased with cumulative arsenic exposure and with arsenic concentration, but at a lesser rate of increase (<xref ref-type="table" rid="t2-ehp-116-1661">Table 2</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res11" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="77">Within each arsenic concentration category, RRs increased with cumulative arsenic exposure (<xref ref-type="fig" rid="f1-ehp-116-1661">Figure 1</xref>).<CoreSc1 atype="GSC" type="Res" conceptID="Res12" novelty="None" advantage="None"/></s>
          <s sid="78">Two characteristics in the figure are noteworthy.<CoreSc1 atype="GSC" type="Res" conceptID="Res13" novelty="None" advantage="None"/></s>
          <s sid="79">First, RRs by cumulative arsenic exposure were consistent with linearity within each concentration category.<CoreSc1 atype="GSC" type="Res" conceptID="Res14" novelty="None" advantage="None"/></s>
          <s sid="80">Tests of the null hypothesis of no departure from linearity were not rejected.<CoreSc1 atype="GSC" type="Res" conceptID="Res15" novelty="None" advantage="None"/></s>
          <s sid="81">Second, estimates of the slope parameters &#947;<italic><sub>i</sub></italic> (i.e., the ERR/mg/m<sup>3</sup>-year) varied significantly (<italic>p</italic>-value for homogeneity of slopes, <italic>p</italic> = 0.02) and generally increased, suggesting a greater exposure&#8211;response relationship with increasing arsenic concentration.<CoreSc1 atype="GSC" type="Res" conceptID="Res16" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="82">The change in the ERR/mg/m<sup>3</sup>-year estimate (i.e., the slope) represents the effect modification by arsenic concentration of the relationship between respiratory cancer and cumulative arsenic exposure.<CoreSc1 atype="GSC" type="Res" conceptID="Res17" novelty="None" advantage="None"/></s>
          <s sid="83"><xref ref-type="fig" rid="f2-ehp-116-1661">Figure 2</xref> plots the slope estimate by mean arsenic concentration for six concentration categories (square symbols, with CIs omitted for clarity), the fitted model 2 using continuous data (solid line), its pointwise 95% CI (dashed lines), and the model for no variation with concentration (model 2 with &#966; = 0; dotted line).<CoreSc1 atype="GSC" type="Res" conceptID="Res18" novelty="None" advantage="None"/></s>
          <s sid="84">The ERR/mg/m<sup>3</sup>-year estimate (&#946;) was &#946; = 0.115 (95% CI 0.07&#8211;0.19) (<xref ref-type="table" rid="t3-ehp-116-1661">Table 3</xref>), and varied significantly with arsenic concentration (<italic>p</italic> &lt; 0.01).<CoreSc1 atype="GSC" type="Res" conceptID="Res19" novelty="None" advantage="None"/></s>
          <s sid="85">After adjusting for cumulative arsenic exposure, the ERR/mg/m<sup>3</sup>-year increased with increasing concentration (estimate of &#966; was 1.123 (95% CI, 0.41&#8211;1.84).<CoreSc1 atype="GSC" type="Res" conceptID="Res20" novelty="None" advantage="None"/></s>
          <s sid="86">Results in the restricted data were similar.<CoreSc1 atype="GSC" type="Res" conceptID="Res21" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="87">Using model 2, we evaluated time since last arsenic exposure as a modifier of the arsenic exposure&#8211;response relationship.<CoreSc1 atype="GSC" type="Obj" conceptID="Obj8" novelty="None" advantage="None"/></s>
          <s sid="88">We focus on the restricted data, although we show results for all data for completeness.<CoreSc1 atype="GSC" type="Res" conceptID="Res22" novelty="None" advantage="None"/></s>
          <s sid="89">Although variations were not statistically significant, the cumulative arsenic exposure effect (&#946;) decreased with time since last arsenic exposure by factors of 1.0, 0.8, and 0.2 for &lt; 5, 5&#8211;14, and &#8805;15 years since last exposure, respectively (<xref ref-type="table" rid="t3-ehp-116-1661">Table 3</xref>; change in deviance = 2.6 and <italic>p</italic> = 0.27 comparing models B0-R and T1-R; or change in deviance = 1.2 and <italic>p</italic> = 0.55 comparing models T2-R and T3-R).<CoreSc1 atype="GSC" type="Res" conceptID="Res23" novelty="None" advantage="None"/></s>
          <s sid="90">The arsenic concentration effect (&#966;) also varied with time since last exposure, but changes in deviance were smaller (<xref ref-type="table" rid="t3-ehp-116-1661">Table 3</xref>; change in deviance = 1.9 and <italic>p</italic> = 0.39 comparing models B0-R and T2-R, or change in deviance = 0.5 and <italic>p</italic> = 0.78 comparing T1-R and T3-R).<CoreSc1 atype="GSC" type="Res" conceptID="Res24" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="91">In the restricted data, there was a suggestion of declining arsenic effects with attained age, but no preference for effect modification of age with either cumulative arsenic exposure or arsenic concentration.<CoreSc1 atype="GSC" type="Res" conceptID="Res25" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>
          <s sid="92">In our study of copper smelter workers, RRs for respiratory cancer increased linearly with cumulative arsenic exposure within categories of arsenic concentration.<CoreSc1 atype="GSC" type="Res" conceptID="Res26" novelty="None" advantage="None"/></s>
          <s sid="93">In addition, we found a direct concentration effect, whereby the slope of the linear exposure&#8211;response relationship increased with arsenic concentration.<CoreSc1 atype="GSC" type="Res" conceptID="Res27" novelty="None" advantage="None"/></s>
          <s sid="94">This pattern implied that for equal cumulative arsenic exposure, the RR of respiratory cancer mortality was greater for cumulative arsenic exposure delivered at higher concentration for shorter duration compared with cumulative exposure delivered at lower concentration for longer duration.<CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/></s>
          <s sid="95">The increase in the exposure&#8211;response relationship within each arsenic concentration category occurred for the full range of concentrations experienced by smelter workers, suggesting that the direct concentration effect was not rate limited within this range.<CoreSc1 atype="GSC" type="Res" conceptID="Res28" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="96">One explanation for the impact of arsenic concentration on the association between cumulative arsenic exposure and respiratory cancer may be found in the concentration-dependent ability of cells to methylate and detoxify arsenic.<CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/></s>
          <s sid="97">Although human populations differ, most humans exposed to arsenic excrete 10&#8211;30% inorganic arsenic, 10&#8211;20% monomethylarsonic acid [MMA(V) and MMA(III)], and 60&#8211;80% dimethylarsinic acid [DMA(V) and DMA(III)].<CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/></s>
          <s sid="98">The pentavalent metabolites MMA(V) and DMA(V) are generally considered less toxic than inorganic arsenite or arsenate.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/></s>
          <s sid="99">Trivalent methylated arsenic metabolites are more genotoxic than inorganic arsenite both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="b41-ehp-116-1661">Styblo et al. 2002</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/></s>
          <s sid="100">Although MMA(III) and DMA(III) can be measured in urine, epidemiologic studies to date have not measured trivalent arsenicals because of the preservation techniques required (<xref ref-type="bibr" rid="b3-ehp-116-1661">Aposhian et al. 2000</xref>; <xref ref-type="bibr" rid="b22-ehp-116-1661">Le et al. 2000</xref>; <xref ref-type="bibr" rid="b31-ehp-116-1661">Mandal et al. 2001</xref>; <xref ref-type="bibr" rid="b43-ehp-116-1661">Valenzuela et al. 2005</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/></s>
          <s sid="101">Epidemiologic studies have used the percent MMA of total inorganic arsenic and the MMA:DMA ratio as surrogate markers of methylation efficiency of ingested arsenic, with increased levels of excreted percent MMA and MMA:DMA ratio in urine indicating reduced methylation efficiency.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/></s>
          <s sid="102">Studies of arsenic in drinking water conducted in Taiwan, Argentina, Bangladesh, and certain areas of the United States have reported elevated risks of bladder and skin cancers associated with an increased percent MMA in urine, as well as a greater MMA:DMA ratio (<xref ref-type="bibr" rid="b1-ehp-116-1661">Ahsan et al. 2007</xref>; <xref ref-type="bibr" rid="b7-ehp-116-1661">Chen et al. 2003a</xref>, <xref ref-type="bibr" rid="b8-ehp-116-1661">2003b</xref>; <xref ref-type="bibr" rid="b15-ehp-116-1661">Hsueh et al. 1997</xref>; <xref ref-type="bibr" rid="b37-ehp-116-1661">Pu et al. 2007</xref>; <xref ref-type="bibr" rid="b39-ehp-116-1661">Steinmaus et al. 2006</xref>; <xref ref-type="bibr" rid="b47-ehp-116-1661">Yu et al. 2000</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/></s>
          <s sid="103">These findings are supported by toxicologic studies showing that methylated arsenicals, particularly MMA(III), have a greater affinity than the nonmethylated forms for protein binding to monothiol, dithiol, and trithiol sites, which can disrupt a number of processes, including gene transcription, glutathione synthesis, DNA methylation, DNA repair, cell division, generation of reactive oxygen species, and signal transduction pathways within cells (<xref ref-type="bibr" rid="b9-ehp-116-1661">Cullen and Reimer 1989</xref>; <xref ref-type="bibr" rid="b19-ehp-116-1661">Kitchin and Wallace 2008</xref>; <xref ref-type="bibr" rid="b20-ehp-116-1661">Kumagai and Sumi 2007</xref>; <xref ref-type="bibr" rid="b26-ehp-116-1661">Lin et al. 1999</xref>, <xref ref-type="bibr" rid="b27-ehp-116-1661">2001</xref>; <xref ref-type="bibr" rid="b32-ehp-116-1661">Mass et al. 2001</xref>; <xref ref-type="bibr" rid="b35-ehp-116-1661">Petrick et al. 2001</xref>; <xref ref-type="bibr" rid="b40-ehp-116-1661">Styblo et al. 2000</xref>; <xref ref-type="bibr" rid="b42-ehp-116-1661">Styblo and Thomas 1997</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/></s>
          <s sid="104">In addition, studies of urinary arsenic methylation patterns of healthy individuals exposed to arsenic in drinking water have shown increased percent MMA relative to total urinary arsenic (<xref ref-type="bibr" rid="b14-ehp-116-1661">Hopenhayn-Rich et al. 1996b</xref>), whereas the percentage of inorganic arsenic and the MMA:DMA ratio decreased when the arsenic concentration in drinking water was reduced to lower levels (<xref ref-type="bibr" rid="b13-ehp-116-1661">Hopenhayn-Rich et al. 1996a</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/></s>
          <s sid="105">These findings suggest that the mechanisms through which arsenic is methylated and excreted can become rate-limited at higher concentrations, perhaps through several steps including enzyme-catalyzed methylation of arsenic through <italic>S</italic>-adenosyl methionine, or glutathione synthesis (<xref ref-type="bibr" rid="b44-ehp-116-1661">Waters et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="106">The toxicologic effects of arsenic described above are multifaceted.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/></s>
          <s sid="107">However, toxicologic studies conducted to date support only the notion that concentration of exposure has a direct impact on the degree of toxicity and/or DNA damage acquired.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/></s>
          <s sid="108">Total cumulative arsenic exposure is a function of both concentration and duration of arsenic exposure.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac23" novelty="None" advantage="None"/></s>
          <s sid="109">Our findings suggest that rates of arsenic biotrans-formation and excretion are concentration dependent.<CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/></s>
          <s sid="110">Toxicologic studies designed to compare cellular and genetic toxicity at a given total cumulative dose delivered at different dose rates are needed to enhance understanding of the mechanistic implications of our results.<CoreSc1 atype="GSC" type="Mot" conceptID="Mot3" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="111">Consistent with our findings, two epidemiologic studies have suggested that the toxic effects from cumulative arsenic exposure in drinking water are greater among individuals exposed at higher, as opposed to lower, concentrations.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac24" novelty="None" advantage="None"/></s>
          <s sid="112">In a case&#8211;control study of arsenic-related skin lesions in a screened population in Bangladesh, about 70% of subjects consumed drinking water with arsenic concentrations &gt; 50 &#956;g/L (<xref ref-type="bibr" rid="b38-ehp-116-1661">Rahman et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac25" novelty="None" advantage="None"/></s>
          <s sid="113">For similar levels of cumulative arsenic exposure, the odds ratios were higher for subjects with older ages at first exposure compared with those younger at first exposure.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac26" novelty="None" advantage="None"/></s>
          <s sid="114">Because older age at first exposure would reflect shorter duration of exposure, the results suggested higher risks for cumulative exposures with shorter durations and correspondingly higher concentrations, as we observed for lung cancer among smelter workers.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac27" novelty="None" advantage="None"/></s>
          <s sid="115">In a case&#8211;control study of bladder cancer in New Hampshire, odds ratios among smokers increased with higher concentrations of toenail arsenic, with risks being greater among individuals with shorter (&lt; 15 years) compared with longer residence in the current home (<xref ref-type="bibr" rid="b18-ehp-116-1661">Karagas et al. 2004</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac28" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="116">A threshold for the carcinogenic effects of arsenic in drinking water at about 150 &#956;g/L, below which there is no risk from exposure, has been suggested (<xref ref-type="bibr" rid="b21-ehp-116-1661">Lamm et al. 2006</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac29" novelty="None" advantage="None"/></s>
          <s sid="117">Although studies of noncancer outcomes, such as arsenical dermatoses, cardiovascular disease, and cerebrovascular disease, do not support a threshold (<xref ref-type="bibr" rid="b2-ehp-116-1661">Ahsan et al. 2006</xref>; <xref ref-type="bibr" rid="b10-ehp-116-1661">Engel et al. 1994</xref>; <xref ref-type="bibr" rid="b38-ehp-116-1661">Rahman et al. 2006</xref>; <xref ref-type="bibr" rid="b46-ehp-116-1661">Yu et al. 2006</xref>), studies of cancer outcomes after relatively low levels of exposure have been limited by low power and potential exposure misclassification (<xref ref-type="bibr" rid="b6-ehp-116-1661">Cantor and Lubin 2007</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac30" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="118">Our results may inform the exposure threshold issue.<CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/></s>
          <s sid="119">In areas of Taiwan with endemic blackfoot disease, <xref ref-type="bibr" rid="b4-ehp-116-1661">Bates et al. (1992)</xref> estimated that consuming drinking water with 470 &#956;g/L arsenic resulted in a lifetime intake of 30,000 mg arsenic.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac31" novelty="None" advantage="None"/></s>
          <s sid="120">Ingestion of drinking water with 150 &#956;g/L arsenic therefore corresponds approximately to a lifetime intake of 9,600 mg arsenic.<CoreSc1 atype="GSC" type="Bac" conceptID="Bac32" novelty="None" advantage="None"/></s>
          <s sid="121">Measurement of urinary arsenic and its metabolites serves as a measure of absorption of inhaled arsenic through the respiratory tract, because arsenic excretion occurs mainly through the kidneys (<xref ref-type="bibr" rid="b45-ehp-116-1661">World Health Organization 2001</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac33" novelty="None" advantage="None"/></s>
          <s sid="122">In a study of smelter workers in Tacoma, Washington, investigators empirically derived the following relationship between inhaled and urinary arsenic levels: airborne arsenic in micrograms per cubic meter = 0.0064 (urine arsenic in micrograms per liter)<sup>1.924</sup> (<xref ref-type="bibr" rid="b11-ehp-116-1661">Enterline et al. 1987</xref>).<CoreSc1 atype="GSC" type="Bac" conceptID="Bac34" novelty="None" advantage="None"/></s>
          <s sid="123">In our data, mean airborne arsenic concentrations for the four categories in <xref ref-type="fig" rid="f1-ehp-116-1661">Figure 1</xref> ranged from 0.29 to 0.65 mg/m<sup>3</sup>, and therefore correspond roughly to urinary arsenic levels from 263 to 400 &#956;g/L.<CoreSc1 atype="GSC" type="Res" conceptID="Res29" novelty="None" advantage="None"/></s>
          <s sid="124">Assuming 2 L urine per day, 250 working days per year, no other sources of arsenic and no accumulation of arsenic in the body (<xref ref-type="bibr" rid="b4-ehp-116-1661">Bates et al. 1992</xref>), the mean durations of exposure, which ranged from 9.7 to 12.1 years for the four categories, correspond to mean total arsenic intakes of 1,315 (= 263 &#215; 2 &#215; 250 &#215; 10 year/1,000), 1,420, 1,649, and 1,996 mg arsenic, respectively.<CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/></s>
          <s sid="125">Thus, cumulative arsenic exposure in the smelter workers corresponded to &lt; 20% of the lifetime arsenic intake at the postulated threshold.<CoreSc1 atype="GSC" type="Res" conceptID="Res30" novelty="None" advantage="None"/></s>
          <s sid="126">Our finding of a linear relationship for the RR of respiratory cancer mortality across the full range of cumulative arsenic exposures within each category of arsenic concentration argues against a threshold at 150 &#956;g/L.<CoreSc1 atype="GSC" type="Res" conceptID="Res31" novelty="None" advantage="None"/></s>
        </p>
        <p>
          <s sid="127">In summary, our cohort study of copper smelter workers revealed a linear relationship between cumulative arsenic exposure and respiratory cancer mortality within categories of arsenic concentration.<CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/></s>
          <s sid="128">In addition, we found a direct concentration effect on the exposure&#8211;response relationship, indicating that for a fixed level of cumulative arsenic exposure, inhalation of higher concentrations of arsenic over shorter durations was more deleterious than inhalation of lower concentrations over longer durations.<CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/></s>
        </p>
      </sec>
      <sec sec-type="display-objects">
        <title>Figures and Tables</title>
        <fig id="f1-ehp-116-1661" position="float">
          <label>Figure 1</label>
          <caption>
            <p>RRs of respiratory cancer mortality by categories of cumulative arsenic exposure (mg/m<sup>3</sup>-years) and arsenic concentration (mg/m<sup>3</sup>) relative to U.S. mortality rates for white males, adjusted to nonexposed workers, and fitted linear ERR models for cumulative arsenic exposure: 0.29 mg/m<sup>3</sup> (<italic>A</italic>), 0.30&#8211;0.39 mg/m<sup>3</sup> (<italic>B</italic>), 0.40&#8211;0.49 mg/m<sup>3</sup> (<italic>C</italic>), and &#8805;0.50 mg/m<sup>3</sup> (<italic>D</italic>). Estimates of the ERR per mg/m<sup>3</sup>-year and 95% CIs for the four concentration categories were as follows: A, 0.016 (&#8211;0.005 to 0.041); B, 0.067 (0.024 to 0.119); C, 0.077 (0.017 to 0.159); D, 0.072 (0.043 to 0.107).</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.g001" xlink:type="simple"/>
        </fig>
        <fig id="f2-ehp-116-1661" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Estimates of ERR per mg/m<sup>3</sup>-year based on a linear RR model within six categories of arsenic concentration (square symbols), fitted model 2 (solid line), its pointwise, two-sided, Wald 95% CI (dashed lines), and model 2 omitting variation with concentration (dotted line; ERR/mg/m<sup>3</sup>/year = 0.04756).</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.g002" xlink:type="simple"/>
        </fig>
        <table-wrap id="t1-ehp-116-1661" position="float">
          <label>Table 1</label>
          <caption>
            <p>Descriptive statistics for the Montana cohort study of copper smelter workers.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.t001" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t2-ehp-116-1661" position="float">
          <label>Table 2</label>
          <caption>
            <p>Summary data, respiratory cancer mortality rates, unadjusted and adjusted SMRs relative to U.S. white males by cumulative arsenic exposure (mg/m<sup>3</sup>-years) and arsenic concentration (mg/m<sup>3</sup>) for the Montana cohort study of copper smelter workers.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.t002" xlink:type="simple"/>
        </table-wrap>
        <table-wrap id="t3-ehp-116-1661" position="float">
          <label>Table 3</label>
          <caption>
            <p>Results of modeling the RR of respiratory cancer by cumulative arsenic exposure and arsenic concentration and variations by time since last exposure (TSLE) and attained age: Montana cohort study of copper smelter workers.</p>
          </caption>
          <graphic alt-version="no" position="float" xlink:href="info:doi/10.1289/ehp.11515.t003" xlink:type="simple"/>
        </table-wrap>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn>
          <p>This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.</p>
        </fn>
      </fn-group>
      <ref-list>
        <title>References</title>
        <ref id="b1-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ahsan</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Kibriya</surname>
                <given-names>MG</given-names>
              </name>
              <name name-style="western">
                <surname>Slavkovich</surname>
                <given-names>V</given-names>
              </name>
              <name name-style="western">
                <surname>Parvez</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Jasmine</surname>
                <given-names>F</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>16</volume>
            <fpage>1270</fpage>
            <lpage>1278</lpage>
          </citation>
        </ref>
        <ref id="b2-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Ahsan</surname>
                <given-names>H</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Parvez</surname>
                <given-names>F</given-names>
              </name>
              <name name-style="western">
                <surname>Zablotska</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Argos</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Hussain</surname>
                <given-names>I</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Arsenic exposure from drinking water and risk of pre-malignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study</article-title>
            <source>Am J Epidemiol</source>
            <volume>163</volume>
            <fpage>1138</fpage>
            <lpage>1148</lpage>
          </citation>
        </ref>
        <ref id="b3-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Aposhian</surname>
                <given-names>HV</given-names>
              </name>
              <name name-style="western">
                <surname>Gurzau</surname>
                <given-names>ES</given-names>
              </name>
              <name name-style="western">
                <surname>Le</surname>
                <given-names>XC</given-names>
              </name>
              <name name-style="western">
                <surname>Gurzau</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Healy</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Lu</surname>
                <given-names>X</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic</article-title>
            <source>Chem Res Toxicol</source>
            <volume>13</volume>
            <fpage>693</fpage>
            <lpage>697</lpage>
          </citation>
        </ref>
        <ref id="b4-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Bates</surname>
                <given-names>MN</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>AH</given-names>
              </name>
              <name name-style="western">
                <surname>Hopenhayn-Rich</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <year>1992</year>
            <article-title>Arsenic ingestion and internal cancers: a review</article-title>
            <source>Am J Epidemiol</source>
            <volume>135</volume>
            <fpage>462</fpage>
            <lpage>476</lpage>
          </citation>
        </ref>
        <ref id="b5-ehp-116-1661">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Breslow</surname>
                <given-names>NE</given-names>
              </name>
              <name name-style="western">
                <surname>Day</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <year>1987</year>
            <source>Statistical Methods in Cancer Research: The Analysis of Cohort Studies</source>
            <publisher-loc>Lyon, France</publisher-loc>
            <publisher-name>International Agency for Research on Cancer</publisher-name>
          </citation>
        </ref>
        <ref id="b6-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cantor</surname>
                <given-names>KP</given-names>
              </name>
              <name name-style="western">
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>222</volume>
            <fpage>252</fpage>
            <lpage>257</lpage>
          </citation>
        </ref>
        <ref id="b7-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>YC</given-names>
              </name>
              <name name-style="western">
                <surname>Guo</surname>
                <given-names>YLL</given-names>
              </name>
              <name name-style="western">
                <surname>Su</surname>
                <given-names>HJJ</given-names>
              </name>
              <name name-style="western">
                <surname>Hsueh</surname>
                <given-names>YM</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>TJ</given-names>
              </name>
              <name name-style="western">
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003a</year>
            <article-title>Arsenic methylation and skin cancer risk in southwestern Taiwan</article-title>
            <source>J Occup Environ Med</source>
            <volume>45</volume>
            <fpage>241</fpage>
            <lpage>248</lpage>
          </citation>
        </ref>
        <ref id="b8-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>YC</given-names>
              </name>
              <name name-style="western">
                <surname>Su</surname>
                <given-names>HJJ</given-names>
              </name>
              <name name-style="western">
                <surname>Guo</surname>
                <given-names>YLL</given-names>
              </name>
              <name name-style="western">
                <surname>Hsueh</surname>
                <given-names>YM</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>TJ</given-names>
              </name>
              <name name-style="western">
                <surname>Ryan</surname>
                <given-names>LM</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2003b</year>
            <article-title>Arsenic methylation and bladder cancer risk in Taiwan</article-title>
            <source>Cancer Causes Control</source>
            <volume>14</volume>
            <fpage>303</fpage>
            <lpage>310</lpage>
          </citation>
        </ref>
        <ref id="b9-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Cullen</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Reimer</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <year>1989</year>
            <article-title>Arsenic speciation in the environment</article-title>
            <source>Chem Rev</source>
            <volume>89</volume>
            <fpage>713</fpage>
            <lpage>764</lpage>
          </citation>
        </ref>
        <ref id="b10-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Engel</surname>
                <given-names>RR</given-names>
              </name>
              <name name-style="western">
                <surname>Hopenhayn-Rich</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Receveur</surname>
                <given-names>O</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <year>1994</year>
            <article-title>Vascular effects of chronic arsenic exposure: a review</article-title>
            <source>Epidemiol Rev</source>
            <volume>16</volume>
            <fpage>184</fpage>
            <lpage>209</lpage>
          </citation>
        </ref>
        <ref id="b11-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Enterline</surname>
                <given-names>PE</given-names>
              </name>
              <name name-style="western">
                <surname>Henderson</surname>
                <given-names>VL</given-names>
              </name>
              <name name-style="western">
                <surname>Marsh</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <year>1987</year>
            <article-title>Exposure to arsenic and respiratory cancer. A reanalysis</article-title>
            <source>Am J Epidemiol</source>
            <volume>125</volume>
            <fpage>929</fpage>
            <lpage>938</lpage>
          </citation>
        </ref>
        <ref id="b12-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hertz-Picciotto</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <year>1993</year>
            <article-title>Observations on the dose-response curve for arsenic exposure and lung cancer</article-title>
            <source>Scand J Work Environ Health</source>
            <volume>19</volume>
            <fpage>217</fpage>
            <lpage>226</lpage>
          </citation>
        </ref>
        <ref id="b13-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hopenhayn-Rich</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Biggs</surname>
                <given-names>ML</given-names>
              </name>
              <name name-style="western">
                <surname>Kalman</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Moore</surname>
                <given-names>LE</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <year>1996a</year>
            <article-title>Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water</article-title>
            <source>Environ Health Perspect</source>
            <volume>104</volume>
            <fpage>1200</fpage>
            <lpage>1207</lpage>
          </citation>
        </ref>
        <ref id="b14-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hopenhayn-Rich</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Biggs</surname>
                <given-names>ML</given-names>
              </name>
              <name name-style="western">
                <surname>Smith</surname>
                <given-names>AH</given-names>
              </name>
              <name name-style="western">
                <surname>Kalman</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>Moore</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <year>1996b</year>
            <article-title>Methylation study of a population environmentally exposed to arsenic in drinking water</article-title>
            <source>Environ Health Perspect</source>
            <volume>104</volume>
            <fpage>620</fpage>
            <lpage>628</lpage>
          </citation>
        </ref>
        <ref id="b15-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Hsueh</surname>
                <given-names>YM</given-names>
              </name>
              <name name-style="western">
                <surname>Chiou</surname>
                <given-names>HY</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>YL</given-names>
              </name>
              <name name-style="western">
                <surname>Wu</surname>
                <given-names>WL</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>MH</given-names>
              </name>
              <etal/>
            </person-group>
            <year>1997</year>
            <article-title>Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>6</volume>
            <fpage>589</fpage>
            <lpage>596</lpage>
          </citation>
        </ref>
        <ref id="b16-ehp-116-1661">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">International Agency for Research on Cancer</collab>
            <year>1980</year>
            <article-title>Evaluation of the Carcinogenic Risk of Some Metals and Metallic Compounds</article-title>
            <source>Monogr Eval Carcinog Risk Chem Hum</source>
            <volume>23</volume>
          </citation>
        </ref>
        <ref id="b17-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <collab xlink:type="simple">International Agency for Research on Cancer</collab>
            <year>1987</year>
            <article-title>Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, Volumes 1 to 42</article-title>
            <source>Monogr Eval Carcinog Risk Chem Hum Suppl</source>
            <volume>7</volume>
          </citation>
        </ref>
        <ref id="b18-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Karagas</surname>
                <given-names>MR</given-names>
              </name>
              <name name-style="western">
                <surname>Tosteson</surname>
                <given-names>TD</given-names>
              </name>
              <name name-style="western">
                <surname>Morris</surname>
                <given-names>JS</given-names>
              </name>
              <name name-style="western">
                <surname>Demidenko</surname>
                <given-names>E</given-names>
              </name>
              <name name-style="western">
                <surname>Mott</surname>
                <given-names>LA</given-names>
              </name>
              <name name-style="western">
                <surname>Heaney</surname>
                <given-names>J</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2004</year>
            <article-title>Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire</article-title>
            <source>Cancer Causes Control</source>
            <volume>15</volume>
            <fpage>465</fpage>
            <lpage>472</lpage>
          </citation>
        </ref>
        <ref id="b19-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kitchin</surname>
                <given-names>KT</given-names>
              </name>
              <name name-style="western">
                <surname>Wallace</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <year>2008</year>
            <article-title>The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity</article-title>
            <source>J Inorg Biochem</source>
            <volume>102</volume>
            <fpage>532</fpage>
            <lpage>539</lpage>
          </citation>
        </ref>
        <ref id="b20-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Kumagai</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Sumi</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <year>2007</year>
            <article-title>Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity</article-title>
            <source>Annu Rev Pharmacol Toxicol</source>
            <volume>47</volume>
            <fpage>243</fpage>
            <lpage>262</lpage>
          </citation>
        </ref>
        <ref id="b21-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lamm</surname>
                <given-names>SH</given-names>
              </name>
              <name name-style="western">
                <surname>Engel</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Penn</surname>
                <given-names>CA</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Feinleib</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Arsenic cancer risk confounder in southwest Taiwan data set</article-title>
            <source>Environ Health Perspect</source>
            <volume>114</volume>
            <fpage>1077</fpage>
            <lpage>1082</lpage>
          </citation>
        </ref>
        <ref id="b22-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Le</surname>
                <given-names>XC</given-names>
              </name>
              <name name-style="western">
                <surname>Ma</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Cullen</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Aposhian</surname>
                <given-names>HV</given-names>
              </name>
              <name name-style="western">
                <surname>Lu</surname>
                <given-names>X</given-names>
              </name>
              <name name-style="western">
                <surname>Zheng</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine</article-title>
            <source>Environ Health Perspect</source>
            <volume>108</volume>
            <fpage>1015</fpage>
            <lpage>1018</lpage>
          </citation>
        </ref>
        <ref id="b23-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
                <suffix>Jr</suffix>
              </name>
            </person-group>
            <year>1969</year>
            <article-title>Arsenic and respiratory cancer in man: an occupational study</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>42</volume>
            <fpage>1045</fpage>
            <lpage>1052</lpage>
          </citation>
        </ref>
        <ref id="b24-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lee-Feldstein</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>1983</year>
            <article-title>Arsenic and respiratory cancer in humans&#8212;follow-up of copper smelter employees in Montana</article-title>
            <source>J Natl Cancer Inst</source>
            <volume>70</volume>
            <fpage>601</fpage>
            <lpage>610</lpage>
          </citation>
        </ref>
        <ref id="b25-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lee-Feldstein</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <year>1986</year>
            <article-title>Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees</article-title>
            <source>J Occup Med</source>
            <volume>28</volume>
            <fpage>296</fpage>
            <lpage>302</lpage>
          </citation>
        </ref>
        <ref id="b26-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lin</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Cullen</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>1999</year>
            <article-title>Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase</article-title>
            <source>Chem Res Toxicol</source>
            <volume>12</volume>
            <fpage>924</fpage>
            <lpage>930</lpage>
          </citation>
        </ref>
        <ref id="b27-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lin</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Del Razo</surname>
                <given-names>LM</given-names>
              </name>
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Wang</surname>
                <given-names>CQ</given-names>
              </name>
              <name name-style="western">
                <surname>Cullen</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes</article-title>
            <source>Chem Res Toxicol</source>
            <volume>14</volume>
            <fpage>305</fpage>
            <lpage>311</lpage>
          </citation>
        </ref>
        <ref id="b28-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Caporaso</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Cigarette smoking and lung cancer: modeling total exposure and intensity</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>15</volume>
            <fpage>517</fpage>
            <lpage>523</lpage>
          </citation>
        </ref>
        <ref id="b29-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Pottern</surname>
                <given-names>LM</given-names>
              </name>
              <name name-style="western">
                <surname>Blot</surname>
                <given-names>WJ</given-names>
              </name>
              <name name-style="western">
                <surname>Tokudome</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Stone</surname>
                <given-names>BJ</given-names>
              </name>
              <name name-style="western">
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
                <suffix>Jr</suffix>
              </name>
            </person-group>
            <year>1981</year>
            <article-title>Respiratory cancer among copper smelter workers: recent mortality statistics</article-title>
            <source>J Occup Med</source>
            <volume>23</volume>
            <fpage>779</fpage>
            <lpage>784</lpage>
          </citation>
        </ref>
        <ref id="b30-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Pottern</surname>
                <given-names>LM</given-names>
              </name>
              <name name-style="western">
                <surname>Stone</surname>
                <given-names>BJ</given-names>
              </name>
              <name name-style="western">
                <surname>Fraumeni</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up</article-title>
            <source>Am J Epidemiol</source>
            <volume>151</volume>
            <fpage>554</fpage>
            <lpage>565</lpage>
          </citation>
        </ref>
        <ref id="b31-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mandal</surname>
                <given-names>BK</given-names>
              </name>
              <name name-style="western">
                <surname>Ogra</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Suzuki</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India</article-title>
            <source>Chem Res Toxicol</source>
            <volume>14</volume>
            <fpage>371</fpage>
            <lpage>378</lpage>
          </citation>
        </ref>
        <ref id="b32-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Mass</surname>
                <given-names>MJ</given-names>
              </name>
              <name name-style="western">
                <surname>Tennant</surname>
                <given-names>A</given-names>
              </name>
              <name name-style="western">
                <surname>Roop</surname>
                <given-names>BC</given-names>
              </name>
              <name name-style="western">
                <surname>Cullen</surname>
                <given-names>WR</given-names>
              </name>
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2001</year>
            <article-title>Methylated trivalent arsenic species are genotoxic</article-title>
            <source>Chem Res Toxicol</source>
            <volume>14</volume>
            <fpage>355</fpage>
            <lpage>361</lpage>
          </citation>
        </ref>
        <ref id="b33-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Morris</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <year>1978</year>
            <article-title>Testimony on proposed standard for exposure to inorganic arsenic (exhibit 28B) in Department of Labor, Occupational Safety and Health Administration: occupational exposures to inorganic arsenic&#8212;final standard</article-title>
            <source>Fed Reg</source>
            <volume>43</volume>
            <fpage>19584</fpage>
            <lpage>19629</lpage>
          </citation>
        </ref>
        <ref id="b34-ehp-116-1661">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">National Research Council</collab>
            <year>2006</year>
            <source>Health Risks from Exposure to Low Levels of Ionizing Radiation (BEIR VII Phase 2)</source>
            <publisher-loc>Washington, DC</publisher-loc>
            <publisher-name>National Academy Press</publisher-name>
          </citation>
        </ref>
        <ref id="b35-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Petrick</surname>
                <given-names>JS</given-names>
              </name>
              <name name-style="western">
                <surname>Jagadish</surname>
                <given-names>B</given-names>
              </name>
              <name name-style="western">
                <surname>Mash</surname>
                <given-names>EA</given-names>
              </name>
              <name name-style="western">
                <surname>Aposhian</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <year>2001</year>
            <article-title>Monomethylarsonous acid (MMA(III)) and arsenite: LD50 in hamsters and <italic>in vitro</italic> inhibition of pyruvate dehydrogenase</article-title>
            <source>Chem Res Toxicol</source>
            <volume>14</volume>
            <fpage>651</fpage>
            <lpage>656</lpage>
          </citation>
        </ref>
        <ref id="b36-ehp-116-1661">
          <citation citation-type="book" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Preston</surname>
                <given-names>DL</given-names>
              </name>
              <name name-style="western">
                <surname>Lubin</surname>
                <given-names>JH</given-names>
              </name>
              <name name-style="western">
                <surname>Pierce</surname>
                <given-names>DA</given-names>
              </name>
              <name name-style="western">
                <surname>McConney</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <source>EPICURE: Risk Regression and Data Analysis Software, Release 2.0</source>
            <publisher-loc>Seattle</publisher-loc>
            <publisher-name>HiroSoft International Corporation</publisher-name>
          </citation>
        </ref>
        <ref id="b37-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Pu</surname>
                <given-names>YS</given-names>
              </name>
              <name name-style="western">
                <surname>Yang</surname>
                <given-names>SM</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>YK</given-names>
              </name>
              <name name-style="western">
                <surname>Chung</surname>
                <given-names>CJ</given-names>
              </name>
              <name name-style="western">
                <surname>Huang</surname>
                <given-names>SK</given-names>
              </name>
              <name name-style="western">
                <surname>Chiu</surname>
                <given-names>AW</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2007</year>
            <article-title>Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>218</volume>
            <fpage>99</fpage>
            <lpage>106</lpage>
          </citation>
        </ref>
        <ref id="b38-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Rahman</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Vahter</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Sohel</surname>
                <given-names>N</given-names>
              </name>
              <name name-style="western">
                <surname>Yunus</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Wahed</surname>
                <given-names>MA</given-names>
              </name>
              <name name-style="western">
                <surname>Streatfield</surname>
                <given-names>PK</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Arsenic exposure and age- and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh</article-title>
            <source>Environ Health Perspect</source>
            <volume>114</volume>
            <fpage>1847</fpage>
            <lpage>1852</lpage>
          </citation>
        </ref>
        <ref id="b39-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Steinmaus</surname>
                <given-names>C</given-names>
              </name>
              <name name-style="western">
                <surname>Bates</surname>
                <given-names>MN</given-names>
              </name>
              <name name-style="western">
                <surname>Yuan</surname>
                <given-names>Y</given-names>
              </name>
              <name name-style="western">
                <surname>Kalman</surname>
                <given-names>D</given-names>
              </name>
              <name name-style="western">
                <surname>Atallah</surname>
                <given-names>R</given-names>
              </name>
              <name name-style="western">
                <surname>Rey</surname>
                <given-names>OA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2006</year>
            <article-title>Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States</article-title>
            <source>J Occup Environ Med</source>
            <volume>48</volume>
            <fpage>478</fpage>
            <lpage>488</lpage>
          </citation>
        </ref>
        <ref id="b40-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Del Razo</surname>
                <given-names>LM</given-names>
              </name>
              <name name-style="western">
                <surname>Vega</surname>
                <given-names>L</given-names>
              </name>
              <name name-style="western">
                <surname>Germolec</surname>
                <given-names>DR</given-names>
              </name>
              <name name-style="western">
                <surname>LeCluyse</surname>
                <given-names>EL</given-names>
              </name>
              <name name-style="western">
                <surname>Hamilton</surname>
                <given-names>GA</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2000</year>
            <article-title>Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells</article-title>
            <source>Arch Toxicol</source>
            <volume>74</volume>
            <fpage>289</fpage>
            <lpage>299</lpage>
          </citation>
        </ref>
        <ref id="b41-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Drobna</surname>
                <given-names>Z</given-names>
              </name>
              <name name-style="western">
                <surname>Jaspers</surname>
                <given-names>I</given-names>
              </name>
              <name name-style="western">
                <surname>Lin</surname>
                <given-names>S</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>2002</year>
            <article-title>The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update</article-title>
            <source>Environ Health Perspect</source>
            <volume>110</volume>
            <issue>suppl 5</issue>
            <fpage>767</fpage>
            <lpage>771</lpage>
          </citation>
        </ref>
        <ref id="b42-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>1997</year>
            <article-title>Binding of arsenicals to proteins in an in vitro methylation system</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <volume>147</volume>
            <fpage>1</fpage>
            <lpage>8</lpage>
          </citation>
        </ref>
        <ref id="b43-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Valenzuela</surname>
                <given-names>OL</given-names>
              </name>
              <name name-style="western">
                <surname>Borja-Aburto</surname>
                <given-names>VH</given-names>
              </name>
              <name name-style="western">
                <surname>Garcia-Vargas</surname>
                <given-names>GG</given-names>
              </name>
              <name name-style="western">
                <surname>Cruz-Gonzalez</surname>
                <given-names>MB</given-names>
              </name>
              <name name-style="western">
                <surname>Garcia-Montalvo</surname>
                <given-names>EA</given-names>
              </name>
              <name name-style="western">
                <surname>Calderon-Aranda</surname>
                <given-names>ES</given-names>
              </name>
              <etal/>
            </person-group>
            <year>2005</year>
            <article-title>Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic</article-title>
            <source>Environ Health Perspect</source>
            <volume>113</volume>
            <fpage>250</fpage>
            <lpage>254</lpage>
          </citation>
        </ref>
        <ref id="b44-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Waters</surname>
                <given-names>SB</given-names>
              </name>
              <name name-style="western">
                <surname>Devesa</surname>
                <given-names>V</given-names>
              </name>
              <name name-style="western">
                <surname>Fricke</surname>
                <given-names>MW</given-names>
              </name>
              <name name-style="western">
                <surname>Creed</surname>
                <given-names>JT</given-names>
              </name>
              <name name-style="western">
                <surname>Styblo</surname>
                <given-names>M</given-names>
              </name>
              <name name-style="western">
                <surname>Thomas</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <year>2004</year>
            <article-title>Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine</article-title>
            <source>Chem Res Toxicol</source>
            <volume>17</volume>
            <fpage>1621</fpage>
            <lpage>1629</lpage>
          </citation>
        </ref>
        <ref id="b45-ehp-116-1661">
          <citation citation-type="book" xlink:type="simple">
            <collab xlink:type="simple">World Health Organization</collab>
            <year>2001</year>
            <source>Environmental Health Criteria 224: Arsenic and Arsenic Compounds</source>
            <edition>2</edition>
            <publisher-loc>Geneva</publisher-loc>
            <publisher-name>World Health Organization</publisher-name>
          </citation>
        </ref>
        <ref id="b46-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yu</surname>
                <given-names>HS</given-names>
              </name>
              <name name-style="western">
                <surname>Liao</surname>
                <given-names>WT</given-names>
              </name>
              <name name-style="western">
                <surname>Chai</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <year>2006</year>
            <article-title>Arsenic carcinogenesis in the skin</article-title>
            <source>J Biomed Sci</source>
            <volume>13</volume>
            <fpage>657</fpage>
            <lpage>666</lpage>
          </citation>
        </ref>
        <ref id="b47-ehp-116-1661">
          <citation citation-type="journal" xlink:type="simple">
            <person-group person-group-type="author">
              <name name-style="western">
                <surname>Yu</surname>
                <given-names>RC</given-names>
              </name>
              <name name-style="western">
                <surname>Hsu</surname>
                <given-names>KH</given-names>
              </name>
              <name name-style="western">
                <surname>Chen</surname>
                <given-names>CJ</given-names>
              </name>
              <name name-style="western">
                <surname>Froines</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <year>2000</year>
            <article-title>Arsenic methylation capacity and skin cancer</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <volume>9</volume>
            <fpage>1259</fpage>
            <lpage>1262</lpage>
          </citation>
        </ref>
      </ref-list>
    </back>
  </article>
</PAPER>